You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CCR5 (CCR5) Antibodies

Full name:
anti-Chemokine (C-C Motif) Receptor 5 Antibodies (CCR5)
On are 1 Chemokine (C-C Motif) Receptor 5 (CCR5) Antibodies from 1 different suppliers available. A total of 1 CCR5 products are currently listed.
AM4-7, CC-CKR-5, CCCKR5, CCR-5, CCR1-L, CCR5, CCR5-L, CD195, CKR-5, CKR5, Cmkbr5, GPCR, IDDM22
list all antibodies Gene Name GeneID UniProt
Anti-Mouse CCR5 CCR5 12774 P51682
Anti-Rat CCR5 CCR5 117029 O08556
CCR5 1234 P51681

Show all species

Show all synonyms

Most Popular Reactivities for anti-CCR5 (CCR5) Antibodies

Select your species and application

anti-Human CCR5 Antibodies:

All available anti-CCR5 Antibodies

Go to our pre-filtered search.

Top referenced anti-CCR5 Antibodies

  1. Human Polyclonal CCR5 Primary Antibody for WB - ABIN306774 : Wu, Gerard, Wyatt, Choe, Parolin, Ruffing, Borsetti, Cardoso, Desjardin, Newman, Gerard, Sodroski: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. in Nature 1996 (PubMed)
    Show all 7 references for ABIN306774

More Antibodies against CCR5 Interaction Partners

Pig (Porcine) Chemokine (C-C Motif) Receptor 5 (CCR5) interaction partners

  1. Porcine vessel wall injury via balloon arthroplasty upregulates expression of CCR5 by coronary artery transmural and perivascular cells in a sequential pattern

Rhesus Monkey Chemokine (C-C Motif) Receptor 5 (CCR5) interaction partners

  1. CCR5 inhibition may provide a cardioprotective benefit in SIV infection by preventing cardiomyocyte CCR5 signaling.

  2. A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.

  3. CCR5 downregulation on CD4(+) T cells by TCR activation has no measurable effect on susceptibility to SAIDS.

  4. CD4 and CD8 T cells are more vulnerable to SIV infection, indicating the the ability to express CCR5 may activate and hassten T cell death by SIV infection in vitro.

  5. Results estimate the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut (show GUSB Antibodies).

  6. observed a significantly higher loss of CCR5(+) CD45RA(-) CD4 (show CD4 Antibodies)(+) T cells in CD8 (show CD8A Antibodies)(+) lymphocyte-depleted macaques than in controls

  7. Virus recovered from CA28 plasma (SHIV(CA28NP)) used both CCR5 and CXCR4 (show CXCR4 Antibodies) for entry, but the virus recovered from lymph node (SHIV(CA28NL)) used CXCR4 (show CXCR4 Antibodies) almost exclusively

Mouse (Murine) Chemokine (C-C Motif) Receptor 5 (CCR5) interaction partners

  1. CCR5 deficiency increased the production of TNF-alpha (show TNF Antibodies) following LPS (show TLR4 Antibodies) treatment through increased activation of the p38 (show CRK Antibodies) pathway in the kidney, resulting in renal apoptosis and leukocyte infiltration and led to exacerbation of LPS (show TLR4 Antibodies)-induced acute kidney injury.

  2. In West Nile virus infection of the central nervous system, CCR5 activity is required to limit viral burden in the cerebral cortex.

  3. CCR5 blockade suppresses B16 melanoma growth by inhibiting of IL-6 (show IL6 Antibodies)-Stat3 (show STAT3 Antibodies) signaling pathway via upregulation of SOCS3 (show SOCS3 Antibodies).

  4. Data show that the activation of mammalian target of rapamycin (show FRAP1 Antibodies) complex mTORC1 during encephalomyocarditis virus infection is chemokine (C-C) receptor 5-dependent and promotes the translation of inducible NO synthase (iNOS (show NOS2 Antibodies)) and cyclooxygenase (COX)-2 (show COX2 Antibodies).

  5. CCL5 (show CCL5 Antibodies)-induced endothelial progenitor cell migration was increased by overexpression of CCR5 and that increase was abolished by addition of CCL5 (show CCL5 Antibodies) antibody, suggesting CCL5 (show CCL5 Antibodies)/CCR5 interaction is involved in chemotactic effects of endothelial progenitor cells.

  6. These findings show that migration and activation of immune cells via CCR5 is required for controlling N. caninum parasites during the early phase of the infection.

  7. our results suggest that the detrimental effects of C5a in this model are partly mediated through CCR5 activation downstream of C5aR1 (show C5AR1 Antibodies), which may be evaluated for potential therapeutic exploitation in ALI/ARDS.

  8. CCR5 blockade promotes M2 macrophage activation and improves locomotor activity after spinal cord injury in mice.

  9. CCR5 KO mice show less cartilage degeneration but no change in bone or synovial response to medial meniscal destabilization.

  10. Results indicate that CCR5 deficiency modifies the nigrostriatal dopaminergic neuronal system and bidirectional interaction between neurons and glial cells via CCR5 might be important for dopaminergic neuronal survival

Cow (Bovine) Chemokine (C-C Motif) Receptor 5 (CCR5) interaction partners

  1. Transcript analysis showed that antigen stimulation of WC1(+)gammadelta T cells substantially increased CCR5 expression.

Human Chemokine (C-C Motif) Receptor 5 (CCR5) interaction partners

  1. ACE (show ACE Antibodies) I/D is associated with Abdominal Aortic Aneurysm , and 1166A>C AT1R (show AGTR1 Antibodies) with the size of the aneurysm, while -1562C>T MMP-9 (show MMP9 Antibodies) and CCR5Delta32 polymorphisms are most probably not associated with Abdominal Aortic Aneurysm in Croatian patients.

  2. There were no associations of CCL5 (show CCL5 Antibodies) gene promoter polymorphism with the risk of diabetic microvascular complications (DMI); However, the 59029A polymorphism in CCR5 might affect individual susceptibility for DMI [Meta-Analysis]

  3. the CXCR3 (show CXCR3 Antibodies)+/CCR5+ expression was higher in the neoplastic as compared to the hyperplastic nodules.

  4. Data suggest that gene therapy that only targets the CC Chemokine Receptor 5 (CCR5) co-receptor fails to suppress HIV-1.

  5. The authors provide the first evidence that shows CCR5 interaction with a dual-tropic HIV-1 Env (show ERVW-1 Antibodies) played a significant role in Env (show ERVW-1 Antibodies)-induced depletion of CD4 (show CD4 Antibodies) T cells.

  6. Data indicate that on addition of the heat-shock proteins GroEL (show GroEL Antibodies)-GroES (show HSPE1 Antibodies) molecular chaperone (show HSP90AA1 Antibodies) system, the folding of the nascent chemokine receptor (show CCR1 Antibodies) type 5 (CCR5) was significantly enhanced.

  7. The results of this study infer CCR5 and CCL5 (show CCL5 Antibodies) participate in the response to tick-borne encephalitis virus, as well as to other neurotropic pathogens.

  8. Enhanced susceptibility of activated endocervical CD4 (show CD4 Antibodies)+ T cells to HIV may be related to increased CCR5 expression by these cell subsets, but did not appear to be due to direct interaction of integrins a4b7 or a4b1 with HIV envelope.

  9. individuals carrying heterozygous or homozygous genotypes (GA+AA) for CCR2 (show CCR2 Antibodies)-64I polymorphisms seem to be at lower risk for cervical lesion [odds ratio (OR) = 0.37, p = 0.0008)]. The same was observed for the A allele (OR = 0.39, p = 0.0002), while no association was detected (p > 0.05) with CCR5-Delta32 polymorphism.

  10. The residues on the N-loop and beta-sheets of MIP-1a (show CCL3 Antibodies) are close to both CCR1 and CCR5, and those in the C-terminal helix region are close to CCR5.

CCR5 Antigen Profile

Antigen Summary

This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. Two transcript variants encoding the same protein have been found for this gene.

Alternative names and synonyms associated with CCR5

  • chemokine (C-C motif) receptor 5 (CCR5) antibody
  • chemokine (C-C motif) receptor 2 (CCR2) antibody
  • C-C chemokine receptor type 5-like (LOC100399144) antibody
  • chemokine (C-C motif) receptor 5 (Ccr5) antibody
  • chemokine (C-C motif) receptor 5 (gene/pseudogene) (CCR5) antibody
  • AM4-7 antibody
  • CC-CKR-5 antibody
  • CCCKR5 antibody
  • CCR-5 antibody
  • CCR1-L antibody
  • CCR5 antibody
  • CCR5-L antibody
  • CD195 antibody
  • CKR-5 antibody
  • CKR5 antibody
  • Cmkbr5 antibody
  • GPCR antibody
  • IDDM22 antibody

Protein level used designations for CCR5

C-C chemokine receptor type 5 , chemokine C-C motif receptor 5 , C-C chemokine receptor 11 like , C-C CKR-5 , CC-CKR-5 , CCR-5 , chemokine receptor 5 , CC chemokine receptor 5 , CC chemokine receptor type 5 , chemokine (C-C motif) receptor 5 , C-C chemokine receptor 5 , C-C chemokine receptor 5 like , C-C chemokine receptor type 2 , C-C chemokine receptor type 5-like , chemokine receptor CCR5 , MIP-1 alpha receptor , chemokine (C-C) receptor 5 , C-C motif chemokine receptor 5 A159A , HIV-1 fusion coreceptor , chemr13

414371 Sus scrofa
420695 Gallus gallus
450128 Pan troglodytes
493769 Felis catus
735311 Macaca mulatta
100048935 Equus caballus
100126710 Papio anubis
100190809 Pongo abelii
420696 Gallus gallus
100399144 Callithrix jacchus
12774 Mus musculus
117029 Rattus norvegicus
497017 Bos taurus
484789 Canis lupus familiaris
100101579 Oryctolagus cuniculus
1234 Homo sapiens
Selected quality suppliers for anti-CCR5 (CCR5) Antibodies
Did you look for something else?